HRA005220
Title:
scEpiChem-organoid
Release date:
2024-05-21
Description:
We developed scEpiChem, an ultra-high-throughput method enabling the simultaneous detection of drug-target engagement and chromatin accessibility in single cell.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
colorectal cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Helab at Peking University
Contact person:
He Aibin
Email:
ahe@pku.edu.cn
Description:
Helab is a search team at College of Future Technology at Peking University, which is superviesd by Prof. Aibin He. We are interested in development of single cell epigenetic technologies to explore development and disease progression.
Individuals & samples
Submitter:   He Aibin / ahe@pku.edu.cn
Organization:   Peking University
Submission date:   2023-08-01
Requests:   -